Blood Tests Required Before Starting Warfarin Therapy
Before initiating warfarin therapy, prothrombin time (PT) with international normalized ratio (INR) and activated partial thromboplastin time (aPTT) along with a complete blood count (CBC), renal and hepatic function panels are essential baseline tests to ensure safe anticoagulation. 1, 2
Essential Baseline Laboratory Tests
- PT/INR: The primary test for monitoring warfarin therapy and establishing baseline coagulation status before starting treatment 3
- aPTT: Important to detect potential presence of lupus anticoagulants and establish baseline hemostasis 3, 1
- Complete blood count with platelet count: Essential to assess bleeding risk and detect potential contraindications to anticoagulation 1
- Renal function panel: Important for dose adjustment in patients with renal impairment 1
- Hepatic function panel: Critical as liver disease affects coagulation factor synthesis and warfarin metabolism 3, 1
Importance of PT/INR Testing
- PT/INR is the most common test used to monitor oral anticoagulant therapy as it reflects depression of vitamin K-dependent factors (II, VII, and X) 3, 2
- The INR standardizes PT results across different laboratories and thromboplastin reagents, making it more reliable than unconverted PT ratio 3
- Baseline PT/INR establishes the patient's pre-treatment coagulation status and helps guide initial dosing 3, 2
Special Considerations
- For patients with suspected lupus anticoagulants, standard PT/INR may be less reliable; additional testing such as prothrombin and proconvertin tests may be considered 3
- Factor II (prothrombin) levels may be the most important determinant of therapeutic efficacy, though standard monitoring relies on PT/INR 4, 5
- Using thromboplastin reagents with higher sensitivity (lower ISI values) improves precision of INR measurements 6, 7
Monitoring After Initiation
- After starting warfarin, INR should be checked daily until therapeutic range is reached and sustained for 2 consecutive days 3
- Follow-up testing should then occur 2-3 times weekly for 1-2 weeks, then less often according to stability of results 8
- Hemoglobin, hematocrit, and platelet count should be monitored at least every 2-3 days for the first 14 days in inpatient settings 1
Common Pitfalls to Avoid
- Underfilling blood collection tubes can lead to excess citrate and spuriously prolonged PT results 3
- Using collection tubes with 3.2% citrate (rather than 3.8%) for blood coagulation studies can reduce this problem 3
- Failure to account for concomitant heparin therapy can affect PT/INR results; blood for PT/INR determination should be drawn at appropriate intervals after heparin administration 2
- Relying on less sensitive thromboplastin reagents may result in less accurate INR values and potentially inadequate anticoagulation 6, 7
Following these guidelines for pre-warfarin laboratory testing helps ensure safe initiation of therapy and reduces the risk of bleeding complications while maintaining effective anticoagulation.